e-DOL cohort: Cohort of Chronic Pain Patients

Sponsor
University Hospital, Clermont-Ferrand (Other)
Overall Status
Recruiting
CT.gov ID
NCT04880096
Collaborator
Institut ANALGESIA (Other)
5,000
22
59.6
227.3
3.8

Study Details

Study Description

Brief Summary

Chronic pain affects approximately 20% of adults, 50% of the elderly population and over 1.5 billion people worldwide. Societal and economic issues are also crucial, as 60% of people with pain are less able or unable to work and 20% say they have lost their jobs because of pain. The overall cost of chronic pain is estimated at around 300 billion euros in the EU. Unfortunately, current treatments for chronic pain have limited effectiveness and important adverse effects. Pain clinics, which support the most complex and refractory cases of chronic pain, as well as general practitioners and patients expect improvements, both in terms of therapeutic efficacy and organization of care.

In order to allow the characterization and a personalized follow-up of chronic pain patients, we have created e-DOL, a smartphone application for patients and a web platform for healthcare professionals in pain clinics. The purpose of this study is to create an e-cohort for the research, and characterization and follow-up of chronic pain patients.

Condition or Disease Intervention/Treatment Phase
  • Other: eDOL

Detailed Description

This first French e-cohort of chronic pain patients will allow real-life follow-up in order to generate big data including various information on chronic pain, associated-comorbidities, pain impacts on sleep, activity and psycho-emotional parameters, sociodemographic characteristics and pain treatments.

These data will be collected with he eDOL tool (smartphone application for patients and web platform for caregivers in pain clinics), integrating numerous repeatable questionnaires, weekly barometers, a therapeutic education module and a conversational agent (chat bot).

All of these data will also be linked with French health insurance care data in order to get an overview of comorbidities and patient care consumption in a medico-economic approach.

The study will include 20 pain clinics and a minimum of 5000 patients followed for 24 months.

Study Design

Study Type:
Observational
Anticipated Enrollment :
5000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Constitution and Analysis of a Cohort of Patients Followed in Pain Clinics and at Home in Real Life
Actual Study Start Date :
Sep 14, 2021
Anticipated Primary Completion Date :
Sep 1, 2026
Anticipated Study Completion Date :
Sep 1, 2026

Arms and Interventions

Arm Intervention/Treatment
chronic pain patients

All adult patients followed-up in participating pain clinics

Other: eDOL
e-health tool (mobile app for patients and web platform for caregivers in pain clinics)

Outcome Measures

Primary Outcome Measures

  1. multidimensional characterisation of chronic pain patients [5 years]

    Multimodal exploratory analysis of the determinants and repercussions of chronic pain, and their evolution in a real-life context, taking into account all environmental events likely to influence chronic pain (treatments, history, co-morbidities, etc.).

Secondary Outcome Measures

  1. Multivariate descriptive analyses [5 years]

    Study the relationships between the measured criteria

  2. Longitudinal analyses [5 years]

    Describe the distribution and temporal evolution of the measured variables

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • All patients with chronic pain

  • patients equipped and regular users of a smartphone

  • Non-opposition to participation in the study

Exclusion Criteria:
  • Patient unable to understand or answer questionnaires

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU de Clermont-Ferrand - Service de Neurologie Clermont-Ferrand Aura France 63000
2 Clermont-Ferrand University Hospital Clermont-Ferrand Aura France 63000
3 APHP Ambroise Paré Boulogne-Billancourt IDF France 92100
4 APHP Saint Antoine Paris IDF France 75012
5 APHP Cochin Paris IDF France 75014
6 Groupe Hospitalier Paris Saint Joseph Paris IDf France 75014
7 CHU Amiens Amiens France 80054
8 CH Bayeux Bayeux France 14400
9 CHU bordeaux Bordeaux France 33000
10 Hospices civils Lyon Bron France 69500
11 CHU Grenoble Grenoble France 38700
12 CHU Limoges Limoges France 87000
13 Ch Lons Le Saunier Lons-le-Saunier France 39000
14 CHU Montepllier Montpellier France
15 CHU Nantes Nantes France 44093
16 CHU Nîmes Nîmes France 30029
17 CHU Rennes Rennes France 35000
18 Chu Rouen Rouen France 76000
19 CHU Saint Etienne Saint-Étienne France 42270
20 Hôpital Civil de Strasbourg Strasbourg France
21 Chu Toulouse Toulouse France 31300
22 CH Voiron Voiron France 38500

Sponsors and Collaborators

  • University Hospital, Clermont-Ferrand
  • Institut ANALGESIA

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier:
NCT04880096
Other Study ID Numbers:
  • RNI 2020 AUTHIER
First Posted:
May 10, 2021
Last Update Posted:
Jun 30, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Clermont-Ferrand
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 30, 2022